#
Title
1

Andrew Bush, Heather Zar, Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma

2

Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability

3

Anne Holland and Christine McDonald

4

Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

5

Sailesh Kotecha on Prematurity-associated lung disease

6

Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations

7

Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change

8

Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis

9

Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma

10

Joan Soriano on Global Epidemiology of Respiratory Disease

11

Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

12

Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

13

Laura Garriga-Grimau on bronchiectasis in children and young people

14

Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS

15

Hjalmar Bouma on sepsis in patients who are immunocompromised

16

Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019

17

Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension

18

Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)

19

Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)

20

Robert Kullberg on empirical antibiotics for Sepsis

21

Heather Zar on early-life RSV disease and long-term respiratory health

22

Margaux Mesle on lives saved by COVID-19 vaccination

23

James Hull on protecting the respiratory health of athletes

24

Eric Lim on treatments for pleural mesothelioma

25

Anne Chang on the burden of chronic respiratory diseases in Indigenous people

26

Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC

27

Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID

28

Sarah Gorst and Tim Nicholson on long COVID outcomes

29

Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19

30

Keith Chappell on a bivalent recombinant vaccine for COVID-19

31

James Chalmers on bronchiectasis across Europe

32

Richard Costello on management of uncontrolled asthma

33

Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer

34

Carol Hodgson on post-discharge outcomes for ECMO patients

35

Emma Grainger on 10 years of The Lancet Respiratory Medicine

36

Vivienne Kahlmann and Catharina Moor on the TIRED study

37

Yves Lacasse on long-term oxygen therapy for COPD

38

Rachael Evans on living with long COVID

39

Daniel Munblit and Dale Needham on core outcomes post-COVID-19

40

Daiana Stolz on antibiotic stewardship in pneumonia

41

Ablo Wachinou on sleep disordered breathing in Benin

42

Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID

43

Dinh Bui on preterm birth and lung function deficits

44

Ruvim Izĭckson on a joint flu and COVID-19 vaccine

45

Wisia Wedzicha on a vaccine for COPD

46

Eileen Rubin on patient-centered ARDS

47

Daniel Altmann on COVID boosters

48

Michael Kreuter on interstitial lung disease

49

Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19

50

Charles Sprung and authors on end-of-life practices in ICUs globally

51

Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma

52

Paul Verweij on COVID-19 associated aspergillosis

53

Ignacio Rubio on COVID-19 pathophysiology and phenotypes

54

Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia

55

Fan Chung on chronic cough and long COVID

56

Mepolizumab and the treatment of chronic rhinosinusitis

57

Inhaled budesonide in the treatment of early COVID-19

58

Tocilizumab and COVID-19

59

Interferon treatment and COVID-19

60

Evaluating deterioration in patients with acute COVID-19

61

Treatment options in patients with systemic sclerosis-associated interstitial lung disease

62

COVID-19 and severe influenza

63

The second wave and homeless populations